Sign in

NCT07106086Completed

Combined Effect of Scapulothoracic Mobilization With Buteyko Breathing on COPD (Chronic Obstructive Pulmonary Disease) Patients

Combined Effect of Scapulothoracic Mobilization With Buteyko Breathing on Pulmonary Parameters Functional Capacity and Balance Among COPD (Chronic Obstructive Pulmonary Disease) Patients

Source: ClinicalTrials.gov · Last updated 6 Aug 2025

Brief summary (registry, in English)

The objective of this study will be to determine the combine effect of scapulothoracic mobilization with Buteyko breathing on pulmonary parameters functional capacity and balance among COPD patient.

Status (registry)
Completed
Study type
Interventional
Enrollment
40 (actual)
First submitted
28 Jul 2025
Start date
20 Jul 2024
Primary completion date
20 Nov 2024
Lead sponsor
Rashid Latif Medical College
Diseases
COPD
NCT number
NCT07106086

What you commit to

  • Study type: Interventional
  • Participants enrolled: 40
  • From 20 Jul 2024 to the primary completion date, 20 Nov 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients diagnosed with a primary pulmonary vascular disease
  • Patients diagnosed with severe psychiatric disorders and cognitive dysfunction
  • Patients diagnosed Musculoskeletal, Rheumatic ,Cardiac/Neurological disorder and Malignancies
  • Patients diagnosed with skin, peripheral vascular disorder excluded

Other

  • Patients diagnosed severe auditory/visual impairments

Who the study is looking for

  • Clinically Diagnosed COPD is confirmed by diagnostic criteria of COPD (forced expiratory volume in 1 second \[FEV1\] \<80% predicted, FEV1/forced vital capacity \[FVC\] \<0.7 predicted) according to the international guideline and the ability to provide inform consent.
  • Patients with Resting Respiratory Rate \>\_ 24

Age in the registry: 40 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Arif memorial teaching hospital
Coordinator of this site? Confirm its status
LahorePakistanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.